D3A.022 – Benign carcinoid tumor of the ascending colon

ICD-10-CM 2027 diagnosis code · Benign neuroendocrine tumors (D3A)

Billable code

ICD-10-CM code D3A.022
Code
D3A.022 (claims format: D3A022)
Description
Benign carcinoid tumor of the ascending colon
Billable
Yes – valid for HIPAA-covered transactions
Valid for
Dates of service October 1, 2026 – September 30, 2027 (FY2027)
Chapter
2. Neoplasms (C00-D49)
Block
D3A Benign neuroendocrine tumors (D3A)
Parent codes
D3A › D3A.0 › D3A.02

Notes inherited from parent codes

Instructional notes at a category or block level apply to every code below it.

D3A – Benign neuroendocrine tumors

Excludes2 (not included here):
  • benign pancreatic islet cell tumors (D13.7)
Use additional code:
  • code to identify any associated endocrine syndrome, such as:
  • carcinoid syndrome (E34.00)
Code also:
  • any associated multiple endocrine neoplasia [MEN] syndromes (E31.2-)

Index terms for D3A.022

Entries in the ICD-10-CM alphabetic index that lead to this code:

Related codes in D3A.02

Frequently asked questions

What is ICD-10 code D3A.022?

D3A.022 is the ICD-10-CM code for benign carcinoid tumor of the ascending colon, in the block D3A (Benign neuroendocrine tumors (D3A)).

Is D3A.022 a billable code?

Yes. D3A.022 is a billable/specific code that can be used to indicate a diagnosis for reimbursement purposes.

What category does D3A.022 belong to?

It belongs to category D3A – Benign neuroendocrine tumors.

Source: CDC/NCHS ICD-10-CM FY2027 code files, tabular list and index. Reference only – code assignment must follow the official ICD-10-CM guidelines and documentation in the medical record.